Transforming growth factor-β1 inhibition of macrophage activation is mediated via Smad3

Frank Werner, Mukesh K. Jain, Mark W. Feinberg, Nicholas E.S. Sibinga, Andrea Pellacani, Philippe Wiesel, Michael T. Chin, James N. Topper, Mark A. Perrella, Mu En Lee

Research output: Contribution to journalArticle

132 Citations (Scopus)

Abstract

Activated macrophages are critical cellular participants in inflammatory disease states. Transforming growth factor (TGF)-β1 is a growth factor with pleiotropic effects including inhibition of immune cell activation. Although the pathway of gene activation by TGF-β1 via Smad proteins has recently been elucidated, suppression of gene expression by TGF-β1 remains poorly understood. We found that of Smad1-Smad7, Smad3 alone was able to inhibit expression of markers of macrophage activation (inducible nitric-oxide synthase and matrix metalloproteinase-12) following lipopolysaccharide treatment in gene reporter assays. Transient and constitutive overexpression of a dominant negative Smad3 opposed the inhibitory effect of TGF-β1. Domain swapping experiments suggest that both the Smad MH-1 and MH-2 domains are required for inhibition. Mutation of a critical amino acid residue required for DNA binding in the MH-1 of Smad3 (R74A) resulted in the loss of inhibition. Transient overexpression of p300, an interactor of the Smad MH-2 domain, partially alleviated the inhibition by TGF-β1/Smad3, suggesting that inhibition of gene expression may be due to increased competition for limiting amounts of this coactivator. Our results have implications for the understanding of gene suppression by TGF-β1 and for the regulation of activated macrophages by TGF-β1.

Original languageEnglish (US)
Pages (from-to)36653-36658
Number of pages6
JournalJournal of Biological Chemistry
Volume275
Issue number47
DOIs
StatePublished - Nov 24 2000
Externally publishedYes

Fingerprint

Macrophage Activation
Macrophages
Transforming Growth Factors
Chemical activation
Genes
Gene expression
Matrix Metalloproteinase 12
Smad Proteins
Gene Expression
Nitric Oxide Synthase Type II
Reporter Genes
Transcriptional Activation
Lipopolysaccharides
Assays
Intercellular Signaling Peptides and Proteins
Amino Acids
Mutation
DNA

ASJC Scopus subject areas

  • Biochemistry

Cite this

Werner, F., Jain, M. K., Feinberg, M. W., Sibinga, N. E. S., Pellacani, A., Wiesel, P., ... Lee, M. E. (2000). Transforming growth factor-β1 inhibition of macrophage activation is mediated via Smad3. Journal of Biological Chemistry, 275(47), 36653-36658. https://doi.org/10.1074/jbc.M004536200

Transforming growth factor-β1 inhibition of macrophage activation is mediated via Smad3. / Werner, Frank; Jain, Mukesh K.; Feinberg, Mark W.; Sibinga, Nicholas E.S.; Pellacani, Andrea; Wiesel, Philippe; Chin, Michael T.; Topper, James N.; Perrella, Mark A.; Lee, Mu En.

In: Journal of Biological Chemistry, Vol. 275, No. 47, 24.11.2000, p. 36653-36658.

Research output: Contribution to journalArticle

Werner, F, Jain, MK, Feinberg, MW, Sibinga, NES, Pellacani, A, Wiesel, P, Chin, MT, Topper, JN, Perrella, MA & Lee, ME 2000, 'Transforming growth factor-β1 inhibition of macrophage activation is mediated via Smad3', Journal of Biological Chemistry, vol. 275, no. 47, pp. 36653-36658. https://doi.org/10.1074/jbc.M004536200
Werner, Frank ; Jain, Mukesh K. ; Feinberg, Mark W. ; Sibinga, Nicholas E.S. ; Pellacani, Andrea ; Wiesel, Philippe ; Chin, Michael T. ; Topper, James N. ; Perrella, Mark A. ; Lee, Mu En. / Transforming growth factor-β1 inhibition of macrophage activation is mediated via Smad3. In: Journal of Biological Chemistry. 2000 ; Vol. 275, No. 47. pp. 36653-36658.
@article{1fd8c3bfdeab4704b93db0179548e609,
title = "Transforming growth factor-β1 inhibition of macrophage activation is mediated via Smad3",
abstract = "Activated macrophages are critical cellular participants in inflammatory disease states. Transforming growth factor (TGF)-β1 is a growth factor with pleiotropic effects including inhibition of immune cell activation. Although the pathway of gene activation by TGF-β1 via Smad proteins has recently been elucidated, suppression of gene expression by TGF-β1 remains poorly understood. We found that of Smad1-Smad7, Smad3 alone was able to inhibit expression of markers of macrophage activation (inducible nitric-oxide synthase and matrix metalloproteinase-12) following lipopolysaccharide treatment in gene reporter assays. Transient and constitutive overexpression of a dominant negative Smad3 opposed the inhibitory effect of TGF-β1. Domain swapping experiments suggest that both the Smad MH-1 and MH-2 domains are required for inhibition. Mutation of a critical amino acid residue required for DNA binding in the MH-1 of Smad3 (R74A) resulted in the loss of inhibition. Transient overexpression of p300, an interactor of the Smad MH-2 domain, partially alleviated the inhibition by TGF-β1/Smad3, suggesting that inhibition of gene expression may be due to increased competition for limiting amounts of this coactivator. Our results have implications for the understanding of gene suppression by TGF-β1 and for the regulation of activated macrophages by TGF-β1.",
author = "Frank Werner and Jain, {Mukesh K.} and Feinberg, {Mark W.} and Sibinga, {Nicholas E.S.} and Andrea Pellacani and Philippe Wiesel and Chin, {Michael T.} and Topper, {James N.} and Perrella, {Mark A.} and Lee, {Mu En}",
year = "2000",
month = "11",
day = "24",
doi = "10.1074/jbc.M004536200",
language = "English (US)",
volume = "275",
pages = "36653--36658",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "47",

}

TY - JOUR

T1 - Transforming growth factor-β1 inhibition of macrophage activation is mediated via Smad3

AU - Werner, Frank

AU - Jain, Mukesh K.

AU - Feinberg, Mark W.

AU - Sibinga, Nicholas E.S.

AU - Pellacani, Andrea

AU - Wiesel, Philippe

AU - Chin, Michael T.

AU - Topper, James N.

AU - Perrella, Mark A.

AU - Lee, Mu En

PY - 2000/11/24

Y1 - 2000/11/24

N2 - Activated macrophages are critical cellular participants in inflammatory disease states. Transforming growth factor (TGF)-β1 is a growth factor with pleiotropic effects including inhibition of immune cell activation. Although the pathway of gene activation by TGF-β1 via Smad proteins has recently been elucidated, suppression of gene expression by TGF-β1 remains poorly understood. We found that of Smad1-Smad7, Smad3 alone was able to inhibit expression of markers of macrophage activation (inducible nitric-oxide synthase and matrix metalloproteinase-12) following lipopolysaccharide treatment in gene reporter assays. Transient and constitutive overexpression of a dominant negative Smad3 opposed the inhibitory effect of TGF-β1. Domain swapping experiments suggest that both the Smad MH-1 and MH-2 domains are required for inhibition. Mutation of a critical amino acid residue required for DNA binding in the MH-1 of Smad3 (R74A) resulted in the loss of inhibition. Transient overexpression of p300, an interactor of the Smad MH-2 domain, partially alleviated the inhibition by TGF-β1/Smad3, suggesting that inhibition of gene expression may be due to increased competition for limiting amounts of this coactivator. Our results have implications for the understanding of gene suppression by TGF-β1 and for the regulation of activated macrophages by TGF-β1.

AB - Activated macrophages are critical cellular participants in inflammatory disease states. Transforming growth factor (TGF)-β1 is a growth factor with pleiotropic effects including inhibition of immune cell activation. Although the pathway of gene activation by TGF-β1 via Smad proteins has recently been elucidated, suppression of gene expression by TGF-β1 remains poorly understood. We found that of Smad1-Smad7, Smad3 alone was able to inhibit expression of markers of macrophage activation (inducible nitric-oxide synthase and matrix metalloproteinase-12) following lipopolysaccharide treatment in gene reporter assays. Transient and constitutive overexpression of a dominant negative Smad3 opposed the inhibitory effect of TGF-β1. Domain swapping experiments suggest that both the Smad MH-1 and MH-2 domains are required for inhibition. Mutation of a critical amino acid residue required for DNA binding in the MH-1 of Smad3 (R74A) resulted in the loss of inhibition. Transient overexpression of p300, an interactor of the Smad MH-2 domain, partially alleviated the inhibition by TGF-β1/Smad3, suggesting that inhibition of gene expression may be due to increased competition for limiting amounts of this coactivator. Our results have implications for the understanding of gene suppression by TGF-β1 and for the regulation of activated macrophages by TGF-β1.

UR - http://www.scopus.com/inward/record.url?scp=0034711282&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034711282&partnerID=8YFLogxK

U2 - 10.1074/jbc.M004536200

DO - 10.1074/jbc.M004536200

M3 - Article

C2 - 10973958

AN - SCOPUS:0034711282

VL - 275

SP - 36653

EP - 36658

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 47

ER -